rs121908215

Variant summary

Our verdict is Pathogenic. The variant received 14 ACMG points: 14P and 0B. PM1PM2PP3_ModeratePP5_Very_Strong

The NM_001127222.2(CACNA1A):​c.877G>A​(p.Gly293Arg) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).

Frequency

Genomes: not found (cov: 32)

Consequence

CACNA1A
NM_001127222.2 missense

Scores

15
2
2

Clinical Significance

Pathogenic/Likely pathogenic criteria provided, multiple submitters, no conflicts P:4O:1

Conservation

PhyloP100: 7.79

Publications

9 publications found
Variant links:
Genes affected
CACNA1A (HGNC:1388): (calcium voltage-gated channel subunit alpha1 A) Voltage-dependent calcium channels mediate the entry of calcium ions into excitable cells, and are also involved in a variety of calcium-dependent processes, including muscle contraction, hormone or neurotransmitter release, and gene expression. Calcium channels are multisubunit complexes composed of alpha-1, beta, alpha-2/delta, and gamma subunits. The channel activity is directed by the pore-forming alpha-1 subunit, whereas, the others act as auxiliary subunits regulating this activity. The distinctive properties of the calcium channel types are related primarily to the expression of a variety of alpha-1 isoforms, alpha-1A, B, C, D, E, and S. This gene encodes the alpha-1A subunit, which is predominantly expressed in neuronal tissue. Mutations in this gene are associated with 2 neurologic disorders, familial hemiplegic migraine and episodic ataxia 2. This gene also exhibits polymorphic variation due to (CAG)n-repeats. Multiple transcript variants encoding different isoforms have been found for this gene. In one set of transcript variants, the (CAG)n-repeats occur in the 3' UTR, and are not associated with any disease. But in another set of variants, an insertion extends the coding region to include the (CAG)n-repeats which encode a polyglutamine tract. Expansion of the (CAG)n-repeats from the normal 4-18 to 21-33 in the coding region is associated with spinocerebellar ataxia 6. [provided by RefSeq, Jul 2016]
CACNA1A Gene-Disease associations (from GenCC):
  • episodic ataxia type 2
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
  • undetermined early-onset epileptic encephalopathy
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, Illumina
  • developmental and epileptic encephalopathy, 42
    Inheritance: AD Classification: STRONG, MODERATE Submitted by: G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • migraine, familial hemiplegic, 1
    Inheritance: AD Classification: STRONG Submitted by: Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
  • spinocerebellar ataxia type 6
    Inheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Orphanet
  • benign paroxysmal torticollis of infancy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • familial or sporadic hemiplegic migraine
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Lennox-Gastaut syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Pathogenic. The variant received 14 ACMG points.

PM1
In a hotspot region, there are 4 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 0 benign, 6 uncertain in NM_001127222.2
PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.911
PP5
Variant 19-13359707-C-T is Pathogenic according to our data. Variant chr19-13359707-C-T is described in ClinVar as Pathogenic/Likely_pathogenic. ClinVar VariationId is 8496.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CACNA1ANM_001127222.2 linkc.877G>A p.Gly293Arg missense_variant Exon 6 of 47 ENST00000360228.11 NP_001120694.1
CACNA1ANM_001127221.2 linkc.877G>A p.Gly293Arg missense_variant Exon 6 of 47 ENST00000638009.2 NP_001120693.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CACNA1AENST00000360228.11 linkc.877G>A p.Gly293Arg missense_variant Exon 6 of 47 1 NM_001127222.2 ENSP00000353362.5
CACNA1AENST00000638009.2 linkc.877G>A p.Gly293Arg missense_variant Exon 6 of 47 1 NM_001127221.2 ENSP00000489913.1
CACNA1AENST00000638029.1 linkc.877G>A p.Gly293Arg missense_variant Exon 6 of 48 5 ENSP00000489829.1
CACNA1AENST00000573710.7 linkc.877G>A p.Gly293Arg missense_variant Exon 6 of 47 5 ENSP00000460092.3
CACNA1AENST00000635727.1 linkc.877G>A p.Gly293Arg missense_variant Exon 6 of 47 5 ENSP00000490001.1
CACNA1AENST00000637769.1 linkc.877G>A p.Gly293Arg missense_variant Exon 6 of 47 1 ENSP00000489778.1
CACNA1AENST00000636012.1 linkc.877G>A p.Gly293Arg missense_variant Exon 6 of 46 5 ENSP00000490223.1
CACNA1AENST00000637736.1 linkc.736G>A p.Gly246Arg missense_variant Exon 5 of 46 5 ENSP00000489861.1
CACNA1AENST00000636389.1 linkc.877G>A p.Gly293Arg missense_variant Exon 6 of 47 5 ENSP00000489992.1
CACNA1AENST00000637432.1 linkc.877G>A p.Gly293Arg missense_variant Exon 6 of 48 5 ENSP00000490617.1
CACNA1AENST00000636549.1 linkc.877G>A p.Gly293Arg missense_variant Exon 6 of 48 5 ENSP00000490578.1
CACNA1AENST00000637927.1 linkc.877G>A p.Gly293Arg missense_variant Exon 6 of 47 5 ENSP00000489715.1
CACNA1AENST00000635895.1 linkc.877G>A p.Gly293Arg missense_variant Exon 6 of 47 5 ENSP00000490323.1
CACNA1AENST00000637276.1 linkc.877G>A p.Gly293Arg missense_variant Exon 6 of 46 5 ENSP00000489777.1
CACNA1AENST00000636768.2 linkn.877G>A non_coding_transcript_exon_variant Exon 6 of 45 5 ENSP00000490190.2
CACNA1AENST00000713789.1 linkn.877G>A non_coding_transcript_exon_variant Exon 6 of 47 ENSP00000519091.1

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
Cov.:
31
GnomAD4 genome
Cov.:
32
Alfa
AF:
0.00
Hom.:
0

ClinVar

Significance: Pathogenic/Likely pathogenic
Submissions summary: Pathogenic:4Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Spinocerebellar ataxia type 6 Pathogenic:1Other:1
Jun 28, 2005
OMIM
Significance:Pathogenic
Review Status:no assertion criteria provided
Collection Method:literature only

- -

-
UniProtKB/Swiss-Prot
Significance:not provided
Review Status:no classification provided
Collection Method:literature only

- -

Episodic ataxia type 2 Pathogenic:1
Jun 28, 2005
OMIM
Significance:Pathogenic
Review Status:no assertion criteria provided
Collection Method:literature only

- -

Episodic ataxia type 2;C4310716:Developmental and epileptic encephalopathy, 42 Pathogenic:1
Jun 05, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change replaces glycine, which is neutral and non-polar, with arginine, which is basic and polar, at codon 293 of the CACNA1A protein (p.Gly293Arg). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individuals with clinical features of episodic ataxia type 2 (PMID: 9345107; Invitae). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 8496). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt CACNA1A protein function with a positive predictive value of 95%. Experimental studies have shown that this missense change affects CACNA1A function (PMID: 11742003, 15985579, 18434528). For these reasons, this variant has been classified as Pathogenic. -

not provided Pathogenic:1
Jan 30, 2024
GeneDx
Significance:Likely pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Published functional studies demonstrate altered channel function (PMID: 15985579); Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 11742003, 11179022, 16325861, 18602318, 32899500, 12707077, 32116539, 9345107, 15985579) -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
1.0
BayesDel_addAF
Pathogenic
0.53
D
BayesDel_noAF
Pathogenic
0.53
CADD
Pathogenic
26
DANN
Uncertain
1.0
DEOGEN2
Pathogenic
0.95
.;D;T;.;.;.;.;.;.;T;.;.;.;T;.
Eigen
Pathogenic
0.80
Eigen_PC
Pathogenic
0.80
FATHMM_MKL
Pathogenic
0.98
D
LIST_S2
Pathogenic
0.99
D;D;D;D;D;D;D;D;.;D;D;D;D;D;D
M_CAP
Pathogenic
0.94
D
MetaRNN
Pathogenic
0.91
D;D;D;D;D;D;D;D;D;D;D;D;D;D;D
MetaSVM
Pathogenic
1.1
D
MutationAssessor
Uncertain
2.8
.;M;.;.;M;.;.;M;.;.;.;.;M;.;.
PhyloP100
7.8
PrimateAI
Pathogenic
0.82
D
PROVEAN
Pathogenic
-6.7
.;D;.;.;.;.;.;.;.;.;.;.;.;.;.
REVEL
Pathogenic
0.92
Sift
Benign
0.047
.;D;.;.;.;.;.;.;.;.;.;.;.;.;.
Sift4G
Pathogenic
0.0
D;D;.;.;.;.;.;.;.;.;.;D;.;.;.
Polyphen
1.0
.;D;.;.;.;.;.;.;.;.;.;.;.;.;.
Vest4
0.95
MutPred
0.56
Loss of catalytic residue at P289 (P = 0.0966);Loss of catalytic residue at P289 (P = 0.0966);Loss of catalytic residue at P289 (P = 0.0966);Loss of catalytic residue at P289 (P = 0.0966);Loss of catalytic residue at P289 (P = 0.0966);.;Loss of catalytic residue at P289 (P = 0.0966);Loss of catalytic residue at P289 (P = 0.0966);Loss of catalytic residue at P289 (P = 0.0966);Loss of catalytic residue at P289 (P = 0.0966);Loss of catalytic residue at P289 (P = 0.0966);Loss of catalytic residue at P289 (P = 0.0966);Loss of catalytic residue at P289 (P = 0.0966);Loss of catalytic residue at P289 (P = 0.0966);Loss of catalytic residue at P289 (P = 0.0966);
MVP
0.98
MPC
2.5
ClinPred
1.0
D
GERP RS
5.4
Varity_R
0.77
gMVP
0.97
Mutation Taster
=4/96
disease causing (ClinVar)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs121908215; hg19: chr19-13470521; API